Ongoing Clinical Trials in Advanced Thyroid Cancer: RET Inhibitors (LOXO-292 & BLU-667), NTRK Inhibitors (Larotrectinib, Entrectinib) & IO

March 18, 2020

0 Comments
Login to view comments. Click here to Login